Scientists identify new therapeutic target in ovarian cancer subtype with poor prognosis
Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists discovered that loss of ARID1A function enh…
